First Affiliated Hospital of Zhejiang University: clinical-trial pipeline
First Affiliated Hospital of Zhejiang University is the sponsor of 262 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 118 are not yet finished and 5 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 154 |
| Phase 2 | 59 |
| Phase 1 | 22 |
| Phase 3 | 10 |
| Phase 1/2 | 8 |
| Phase 4 | 5 |
| Early phase 1 | 2 |
| Phase 2/3 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 95 |
| Recruiting | 81 |
| Completed | 43 |
| Not yet recruiting | 31 |
| Active, not recruiting | 6 |
| Terminated | 4 |
| Withdrawn or not authorised | 2 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 105 |
| Psychiatry and mental health | 29 |
| Gastroenterology and liver | 22 |
| Infectious disease and vaccines | 19 |
| Cardiovascular | 18 |
| Immunology and rheumatology | 15 |
| Rare and genetic diseases | 12 |
| Neurology | 11 |
| Respiratory | 8 |
| Haematology | 7 |
| Metabolic and endocrine (diabetes, obesity) | 7 |
| Nephrology and urology | 7 |
Countries
| Country | Trials |
|---|---|
| China | 240 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-08 | New trial posted | Vitamin D Status and Its Influencing Factors in Zhejiang Province: A Multicenter Cross-Se… |
| 2026-09-11 | New trial posted | 18F-S2P PET Imaging in the Evaluation of Large Artery Atherosclerosis |
| 2026-08-31 | New trial posted | Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD |
| 2026-08-28 | New trial posted | GMPA Versus PPI for Gastric Protection and aGVHD Risk |
| 2026-08-26 | New trial posted | SHR-A1811 Monotherapy or Sequential THPy as Neoadjuvant Therapy for Stage II-III HER2-Pos… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT07692841 | Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors | Phase 3 | Recruiting | China |
| NCT07707687 | Safety and Efficacy of Eculizumab in High-risk TA-TMA | Phase 2 | Recruiting | China |
| NCT07372378 | Association of Different Tidal Volumes and Postoperative Pulmonary Complications | Not applicable | Not yet recruiting | |
| NCT07616648 | Effects of Opioid Drugs on Sleep and Emotion in Patients With Moderate to Severe Cancer Pain | Not applicable | Recruiting | China |
| NCT06572813 | Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer | Phase 1/2 | Recruiting | China |
| NCT07866391 | Vitamin D Status and Its Influencing Factors in Zhejiang Province: A Multicenter Cross-Sectional Study | Not applicable | Recruiting | China |
| NCT06088628 | Micro-expressions in Patients With Prolonged Disorders of Consciousness | Not applicable | Recruiting | China |
| NCT04715802 | Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel | Not applicable | Active, not recruiting | China |
| NCT06621212 | Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML | Phase 2 | Recruiting | China |
| NCT07554807 | A Randomized, Double-blind, Placebo-controlled, Prospective, Multi-center Trial Evaluating the Improvement of… | Phase 3 | Not yet recruiting | China |
| NCT07086274 | Individualized Location-based rTMS for Migraine Treatment: A Multicenter Clinical Study | Not applicable | Not yet recruiting | China |
| NCT07142421 | A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastat… | Phase 2 | Active, not recruiting | China |
| NCT07635992 | A Clinical Study Evaluating the Safety, Tolerability, and Effect on HIV Reservoir of Ibalizumab Combined With… | Phase 1 | Not yet recruiting | |
| NCT07423728 | CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors | Not applicable | Recruiting | China |
| NCT06864013 | SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advance… | Phase 2 | Recruiting | China |
| NCT06445881 | Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment | Phase 2 | Recruiting | China |
| NCT07198867 | A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia | Phase 1 | Recruiting | China |
| NCT07114185 | A Prospective Study of Discomfort Symptoms in Patients With Aortic Disease After Endovascular Intervention | Not applicable | Not yet recruiting | China |
| NCT06682195 | Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02) | Phase 2 | Recruiting | China |
| NCT06786299 | Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adu… | Early phase 1 | Not yet recruiting | China |
| NCT05480150 | Chinese Longitudinal and Systematic Study of Bioplar Disorder | Not applicable | Recruiting | China |
| NCT07184853 | Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD | Not applicable | Recruiting | China |
| NCT07122674 | 18F-Pentixafor PET in Hematologic Malignancies | Not applicable | Recruiting | China |
| NCT07794514 | Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD | Not applicable | Recruiting | China |
| NCT07347990 | Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiop… | Not applicable | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "First Affiliated Hospital of Zhejiang University clinical trials: 118 open, 12 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/first-affiliated-hospital-of-zhejiang-university/, data as of 2026-10-25.